Stay updated on Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Sign up to get notified when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision/version was updated from **v3.5.2** to **v3.5.3**, indicating a site release rather than a change to the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the previous revision was v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:49.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:52:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Tuberculosis as an item. Introduced a new resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-18T16:31:38.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the earlier Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:57:15.000Z thumbnail image

Stay in the know with updates to Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Standard vs Double Dose Dolutegravir in HIV/TB Clinical Trial page.